| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |